BioUtah News
-
Alucent Biomedical Announces First Patient Enrolled in First in Human Natural Vascular Scaffolding Clinical Trial
Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia
-
Inherent Biosciences awarded NIH SBIR Phase I Grant to commercialize innovative diagnosis of non-obstructive azoospermia (the most severe form of sperm dysfunction)
Inherent Biosciences announced an award from the National Institute of Child Health and Human Development’s Fertility and Infertility…
-
Recursion is Granted Fast Track Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
Recursion is Granted Fast Track Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
-
FDA Clears Four New Coronary Micro Support Catheters
Non-tapered metal-alloy support catheter platform receives FDA clearance for use in coronary and peripheral vasculature.
-
JUSTICE CHRISTINE DURHAM JOINS WILSON SONSINI’S LITIGATION DEPARTMENT IN SALT LAKE CITY
Justice Durham’s Addition as Senior Of Counsel Bolsters the Firm’s Appellate Practice as Wilson Sonsini Continues to Grow…
-
Renalytix plc successful completion of $30.0 million financing package
Renalytix announced the successful completion of $30.0 million financing package
-
CURTIS, CRAIG INTRODUCE BILL TO IMPROVE ACCESS TO GENERIC TREATMENTS
CURTIS, CRAIG INTRODUCE BILL TO IMPROVE ACCESS TO GENERIC TREATMENTS
-
Taylor Randall inaugurated as President of University of Utah
Taylor Randall inaugurated as President of University of Utah
-
IDbyDNA Awarded Additional DARPA Funding to Continue Development of DIGET Program to Support Detection of Infectious Disease for US Military Applications
Funding to Enable Continued Development of Precision Metagenomics Advancing Platform
-
Curavit Named Runner up in BioUtah’s 2022 Entrepreneur & Investor Life Sciences Summit Pitch Competition
Donates Monetary Winnings to Biohive’s Non Profit Work to Bring STEM Education to Underrepresented Communities
-
NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED CRANIOMAXILLOFACIAL DEVICES
SINTX Technologies announced a Phase 1 grant of $300k awarded by the National Institutes of Health (NIH) to…
-
Updated Interim Data from Clene Nanomedicine’s RESCUE-ALS Open-Label Extension Study to be Presented in Emerging Science Program at 2022 AAN Annual Meeting
Results show significant survival benefit in participants who entered open-label extension of study of CNM-Au8®, a gold nanocrystal…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
